Current Report Filing (8-k)
19 September 2014 - 5:45PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): September 18, 2014
(Exact Name of Registrant as Specified
in its Charter)
Nevada |
|
000-54770 |
|
45-0704149 |
(State or Other
Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2544 Tarpley Road Suite 12, Carrollton, TX 75006 |
(Address of Principal Executive Office) (Zip Code) |
Registrant's telephone number, including
area code: 214-666-8364
____________________________________
(former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2 below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 Other Events.
Previously, on August 19, 2014, Med-Cannabis Pharma,
Inc. (the “Company”) announced that it had opened two medical marijuana facilities in Washington. One is located in
Port Townsend and one in Port Ludlow.
As of today, the Company has disassociated itself with
operations at both of these facilities. Prior management of the Port Townsend facility failed to follow Company policies and procedures
and was insubordinate. As a result, the Company has determined it to be in its best interest to no longer be involved in either
of these operations.
The Company is in the process of opening a store in
Pierce County, Washington which should be operating within the next few weeks.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
September 18, 2014 |
MED-CANNABIS PHARMA, INC. |
|
|
|
/s/ Graciela Moreno |
|
|
|
Graciela Moreno, CEO |
|
|
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Pegasus Companies (CE) (USOTC:PEGX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024